- NOK5.14bn
- NOK5.07bn
- NOK699.77m
Brief: Medistim Reports Q2 EBIT Of NOK 65.3 Million
Norway's Medistim Q1 sales rise to record high
Brief: Medistim Q1 EBIT NOK 57.1 Million
Norway's Medistim Q4 sales rise 20.6% driven by strong growth in Americas, EMEA
Brief: Medistim To Propose Dividend Of Nok 8.00 Per Share
Brief: Medistim CCO Buys About NOK 535,000 Worth Of Co's Shares
Brief: Medistim Q3 EBIT NOK 40.6 Million
Brief: Medistim Q2 EBIT NOK 54.1 Million
Brief: Medistim Q1 EBIT NOK 59.2 Mln
Brief: Medistim To Start Share Buy-Back Programme On March 11, 2025
Brief: Medistim Q4 EBIT NOK 25.8 Million
Brief: Medistim Q3 Sales Up 7%
Brief: Medistim Gets EU Mdr Certificates For Miraq Systems And Ttfm Probes
Brief: Medistim Q2 EBIT NOK 41.3 Million
Brief: Medistim Q1 EBIT NOK 32.1 Million
Brief: Medistim Transfers 8000 Shares To CEO's Company K2 Consulting
Brief: Medistim Q4 Sales NOK 135.6 Mln
Brief: Medistim Q4 EBIT NOK 22.3 Million
Brief: Medistim Opens Direct Sales Office In Sweden